Effector CD4 and CD8 T cells and their role in the tumor microenvironment
- PMID: 23242673
- PMCID: PMC3717059
- DOI: 10.1007/s12307-012-0127-6
Effector CD4 and CD8 T cells and their role in the tumor microenvironment
Abstract
T cells in tumors-the so-called tumor infiltrating lymphocytes (TIL) have been studied intensively over the past years. Compelling evidence point to a clinical relevance for high numbers of T cells at the tumor site with CD8 memory T cells as a key denominator for overall survival (OS) in patients with colo-rectal cancer (CRC), and also for others solid cancers. These data goes hand in hand with studies of clonality of TIL showing the T cells among TIL are expanded clonally, and also that tumor specific T cells of CD4 as well as CD8 type are enriched at the tumor site. The tumor microenvironment is hostile to T cell function e.g., due to expression of enzymes that depletes the amino acids tryptophan and arginine, high concentration of tumor secreted lactate, and presence innate cells or regulatory T cells both with suppressive activity. Analyses of the specificity of TILs in melanoma demonstrate that quite few known antigens are in fact recognized by these cultures underscoring patient unique and/or mutated antigens may represent important target for recognition.
Similar articles
-
Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.Cancer. 1994 Aug 15;74(4):1275-82. doi: 10.1002/1097-0142(19940815)74:4<1275::aid-cncr2820740416>3.0.co;2-q. Cancer. 1994. PMID: 7914469
-
Functional Heterogeneity of CD4+ Tumor-Infiltrating Lymphocytes With a Resident Memory Phenotype in NSCLC.Front Immunol. 2018 Nov 16;9:2654. doi: 10.3389/fimmu.2018.02654. eCollection 2018. Front Immunol. 2018. PMID: 30505306 Free PMC article.
-
Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.J Immunol. 1989 Nov 15;143(10):3404-11. J Immunol. 1989. PMID: 2509557
-
Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook.Cancer J. 2012 Mar-Apr;18(2):160-75. doi: 10.1097/PPO.0b013e31824d4465. Cancer J. 2012. PMID: 22453018 Free PMC article. Review.
-
Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response.J Immunol Res. 2016;2016:8941260. doi: 10.1155/2016/8941260. Epub 2016 May 22. J Immunol Res. 2016. PMID: 27314056 Free PMC article. Review.
Cited by
-
Real-time metabolic profiling of oesophageal tumours reveals an altered metabolic phenotype to different oxygen tensions and to treatment with Pyrazinib.Sci Rep. 2020 Jul 21;10(1):12105. doi: 10.1038/s41598-020-68777-7. Sci Rep. 2020. PMID: 32694701 Free PMC article.
-
Prognostic and predictive value of immunological parameters for chemoradioimmunotherapy in patients with pancreatic adenocarcinoma.Br J Cancer. 2015 Mar 17;112(6):1027-36. doi: 10.1038/bjc.2015.72. Br J Cancer. 2015. PMID: 25742476 Free PMC article. Clinical Trial.
-
Clinical significance of herpes virus entry mediator expression in hepatitis B virus-related hepatocellular carcinoma.Oncol Lett. 2020 Oct;20(4):19. doi: 10.3892/ol.2020.11880. Epub 2020 Jul 16. Oncol Lett. 2020. PMID: 32774492 Free PMC article.
-
Targeted drug delivery system for ovarian cancer microenvironment: Improving the effects of immunotherapy.Front Immunol. 2022 Nov 3;13:1035997. doi: 10.3389/fimmu.2022.1035997. eCollection 2022. Front Immunol. 2022. PMID: 36405688 Free PMC article.
-
Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma.Front Immunol. 2024 Jan 30;15:1283364. doi: 10.3389/fimmu.2024.1283364. eCollection 2024. Front Immunol. 2024. PMID: 38357542 Free PMC article.
References
-
- Andersen MH, Ostergaard Pedersen L, Capeller B, Bröcker EB, Becker JC, thor Straten P. Spontaneous cytoxic T-cell responses against survivin-derived MHC class I restricted T-cell epitopes in situ as well as ex vivo in cancer patients. Cancer Res. 2001;61:5964–5968. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous